39 results
S-3ASR
EX-1.2
ARVN
Arvinas Inc
7 Nov 23
Automatic shelf registration
5:24pm
and disbursements of Agents’ counsel incident to any required review and approval by FINRA of the terms of the sale of the Shares, (vii) listing fees … of the Shares, and (ix) all other reasonable costs and expenses incident to the performance of its obligations hereunder that are not otherwise
8-K
EX-3.1
ARVN
Arvinas Inc
21 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:32pm
incident to the office of the chief executive or that are delegated to such officer by the Board of Directors. The President shall perform such other … prescribe. In addition, the Secretary shall perform such duties and have such powers as are incident to the office of the secretary, including without
8-K
EX-99.1
ARVN
Arvinas Inc
8 Dec 22
Regulation FD Disclosure
8:19am
. incident population per year from SEER database CDK: cyclin-dependent kinases, Pi3K: phosphoinositide 3-kinase; mTOR: mammalian target of rapamycin
8-K
EX-99.1
ARVN
Arvinas Inc
22 Nov 22
Regulation FD Disclosure
5:26pm
targeted inhibitors mTOR inhibitors or PIK3 inhibitors Fulvestrant *U.S. incident population per year from SEER database CDK: cyclin-dependent kinases
8-K
EX-99.2
afsx5w
10 Dec 21
Regulation FD Disclosure
8:16am
424B5
6oxpt8f
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-1.1
u9favtc6
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.1
w37cx
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-1.1
srfjqkv7jp1d ijydq3
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
424B5
mofbyg rjrd9idd
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
zkkv8i28s
14 Dec 20
Prospectus supplement for primary offering
4:48pm
S-3ASR
yf7q5 tx83k2
14 Dec 20
Automatic shelf registration
4:02pm